Perseus Proteomics
4882.TTSE GROWTHPharmaceutical
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 8
| SBI SECURITIES Co., Ltd. | 4.11% |
| FUJIFILM Corporation | 4.11% |
| NOMURA INTERNATIONAL PLC | 0.99% |
| Barclays Capital Securities Ltd. | 0.83% |
| Macquarie Bank Limited | 0.63% |
| Nomura Securities Co., Ltd. | 0.00% |
| Barclays Securities Japan Limited | 0.00% |
| Barclays Bank PLC | 0.00% |
Ownership history · 69
| Holder | Ratio | Change |
|---|---|---|
| Barclays Capital Securities Ltd.2024-03-14 · amended | 1.78% | +0.46pp |
| Barclays Bank PLC2024-03-14 · amended | 10.50% | no change |
| Barclays Securities Japan Limited2024-03-14 · amended | 0.00% | no change |
| Barclays Capital Securities Ltd.2024-03-14 · amended | 1.32% | -0.56pp |
| Barclays Bank PLC2024-03-14 · amended | 10.50% | -0.79pp |
| Barclays Securities Japan Limited2024-03-14 · amended | 0.00% | no change |
| Barclays Capital Securities Ltd.2024-03-14 · amended | 1.88% | +0.62pp |
| Barclays Bank PLC2024-03-14 · amended | 11.29% | -1.02pp |
| Barclays Securities Japan Limited2024-03-14 · amended | 0.00% | no change |
| Barclays Capital Securities Ltd.2024-03-14 · amended | 1.26% | -0.18pp |
| Barclays Bank PLC2024-03-14 · amended | 12.31% | -3.12pp |
| Barclays Securities Japan Limited2024-03-14 · amended | 0.00% | no change |
| Barclays Capital Securities Ltd.2024-03-14 · amended | 1.44% | +0.20pp |
| Barclays Bank PLC2024-03-14 · amended | 15.43% | -1.34pp |
| Barclays Securities Japan Limited2024-03-14 · amended | 0.00% | no change |
| Barclays Capital Securities Ltd.2024-03-14 · amended | 1.24% | +0.18pp |
| Barclays Bank PLC2024-03-14 · amended | 16.77% | -1.18pp |
| Barclays Securities Japan Limited2024-03-14 · amended | 0.00% | no change |
| Barclays Capital Securities Ltd.2024-03-14 · amended | 1.06% | -0.15pp |
| Barclays Bank PLC2024-03-14 · amended | 17.95% | -1.15pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.